Non-invasive Pulse Wave Tonometer Market Snapshot (2022 to 2032)

[294 Pages Report] The global non-invasive pulse wave tonometer market size is expected to be valued at US$ 104.3 Million in 2022. Blood flow in the body should be proper to maintain health and also reduce the risk of heart and other problems associated with blood flow. As the blood flow starts its journey from the heart and flows through various veins and arteries. Blood is a very good carrier that can carry nutrients and drugs to different parts of the body.

Data Points Key Statistics
Non-invasive Pulse Wave Tonometer Market Value 2022 US$ 104.3 Million
Non-invasive Pulse Wave Tonometer Market Projected Value (2032) US$ 194 Million
Non-invasive Pulse Wave Tonometer Market CAGR (2022 to 2032) 5.8%

The non-invasive pulse wave tonometer is a very good device that can help to understand the flow pattern and provide the information so that the proper treatment can be provided. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Non-invasive Pulse Wave Tonometer Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.7%. The proper monitoring of blood flow helps to manage the flow of blood and also help the doctors and another healthcare professional to monitor the patients for various disorders such as COPD (Chronic Obstructive Pulmonary Disease), hypertension, and other problem, non-invasive pulse wave tonometer is used mainly consider for the heart-related problem. Nowadays most treatment centers are using these devices.

Non-invasive pulse wave tonometer is mostly used for monitoring blood flow and understanding the various diseases, to provide treatment. Various innovations are going on for developing the product to provide real-time monitoring of flow and provide treatment. The increasing number of patients and technological enhancement is the major potential for the non-invasive pulse wave tonometer market. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.

Which Drivers Underpin Non-invasive Pulse Wave Tonometer Industry Expansion?

Increased Product Innovation Likely to Augment Non-invasive Pulse Wave Tonometer Sales

Non-invasive pulse wave tonometer is a growing market over the forecast period, as the number of patients is increasing related to heart, hypertension, and others. According to the British Lung Foundation, approx. 1.2 million people are suffering from COPD. The number of patients who are suffering from heart-related problems is also increasing in every region of the world.

The players are also coming up with new product innovations to make the product portable and provide in-depth monitoring of blood flow. The major strength of the system is that it can monitor the flow of blood non-invasive, while in the traditional case, the catheter was inserted to monitor the flow.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are limiting the Growth of the Non-invasive Pulse Wave Tonometer Market?

High Rates of Investment to Impede the Growth

Although Non-invasive Pulse Wave Tonometer offers good ROI in the long run, the high initial investment is a deterrent for many organizations.

The high cost along with awareness and viability of the product the hinderers of the non-invasive pulse wave tonometer market.

Region-wise Insights

Will North America Continue Dominance in the Global Non-invasive Pulse Wave Tonometer Market?

Rising Market Competition to Boost the Market Growth in North America

The North American non-invasive pulse wave tonometer market is expected to accumulate a market share of 33.7% in 2022. North America is dominating and contributing the leading shares to the non-invasive pulse wave tonometer market in terms of revenue and is expected to register significant growth over a forecast period due to the increasing market competition.

The rising prevalence of glaucoma in the region is also adding to the market growth. According to the American Academy of Ophthalmology (AAO), glaucoma affects over 2.7 million of the population aged 40 and older in the USA

How big is the Non-invasive Pulse Wave Tonometer Market in Europe?

Rising Prevalence of Glaucoma Risk Factors to Boost Market Growth in Europe

The European region is anticipated to hold a market share of 30.8%. According to the WHO, there are over 60 million people living with diabetes in the European region. This is mainly due to rising behavioral risk factors such as smoking, alcohol consumption, unhealthy food habits, and a sedentary lifestyle.

Europe is expected to contribute to moderate revenue market share and register a healthy growth rate in the global Non-invasive Pulse Wave Tonometer market due to the rising prevalence of glaucoma risk factors such as diabetes, myopia, and hypertension in the region.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-ups for Non-invasive Pulse Wave Tonometer Market

Some key start-ups in the Non-invasive Pulse Wave Tonometer market include:

  • Tucson medical start-up CATS Tonometer won federal clearance to market a disposable version of its device to measure internal eye pressure, with plans to start selling the instrument this fall. The USA Food and Drug Administration approved CATS Tonometer’s disposable version of a prism device that increases the accuracy of a common instrument that measures eye pressure to diagnose diseases such as glaucoma. The company, founded in 2015 by the University of Arizona alumni Dr. Sean McCafferty, won FDA clearance for a reusable version of its patented prism in 2018. Market clearance is a form of FDA market approval mainly based on a medical device’s similarity to an already-approved device
  • iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behavior outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) is the only modifiable risk factor for glaucoma progression, disease management is centered on reducing IOP. Most patients can utilize iCare HOME2 simply by following the advice and guidance in the instruction materials, freeing up healthcare professionals’ precious time. iCare HOME2’s smart light guide helps the patient position the device correctly and make the measurements effortlessly and accurately, every time.

Who are the Leading Players in the Non-invasive Pulse Wave Tonometer Market?

Prominent players in the Non-invasive Pulse Wave Tonometer market are ADInstruments, Millar, DiaTecne s.r.l. and AtCor Medical Pty Ltd., and various other regional players.

  • In March 2021, iCare launched a digitally-driven tonometer, iCare Home 2, for patient home use, which has a fully integrated app for IOS and android and utilizes the cloud for data security and storage. It allows patients to self-measure their IOP (intraocular pressure) without the need to come to a clinic or hospital.
  • In February 2021, Reichert Technologies, a business unit of AMETEK Inc., launched Tono-Vera Vet Tonometer with ActiView Positioning System. It utilizes rebound tonometer technology, which eliminates the need for a topical anesthetic.

Report Scope

Report Attribute Details
Growth Rate CAGR of 5.8% from 2022 to 2032
Market Value in 2022 US$ 104.3 Million
Market Value in 2032 US$ 194 Million
Base Year for Estimation 2021
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in US$ Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • End-User
  • Indication
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)
Key Countries Profiled
  • The USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • India
  • Malaysia
  • Singapore
  • Thailand
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • ADInstruments
  • Millar
  • DiaTecne s.r.l
  • AtCor Medical Pty. Ltd.
  • Haag Streit AG
  • Ametek Industries Technology
  • Ray Vision International Corporation
  • Crystalvue Medical
  • Shanghai Vowish Optical Co. Ltd.
Customization Available upon Request

Key Segments Covered in the Non-invasive Pulse Wave Tonometer Industry Analysis

Non-invasive Pulse Wave Tonometer Market by End User:

  • Non-invasive Pulse Wave Tonometers for Hospitals
  • Non-invasive Pulse Wave Tonometers for Clinics
  • Non-invasive Pulse Wave Tonometers for Other End Users

Non-invasive Pulse Wave Tonometer Market by Indication:

  • Non-invasive Pulse Wave Tonometers for Hypertension
  • Non-invasive Pulse Wave Tonometers for Renal Disease
  • Non-invasive Pulse Wave Tonometers for COPD
  • Non-invasive Pulse Wave Tonometers for Diabetes
  • Non-invasive Pulse Wave Tonometers for Heart Failure
  • Non-invasive Pulse Wave Tonometers for Other Disease Indications

Non-invasive Pulse Wave Tonometer Market by Region:

  • North America Non-invasive Pulse Wave Tonometer Market
  • Latin America Non-invasive Pulse Wave Tonometer Market
  • Europe Non-invasive Pulse Wave Tonometer Market
  • South Asia Non-invasive Pulse Wave Tonometer Market
  • East Asia Non-invasive Pulse Wave Tonometer Market
  • Oceania Non-invasive Pulse Wave Tonometer Market
  • Middle East and Africa (MEA) Non-invasive Pulse Wave Tonometer Market

Frequently Asked Questions

What is the expected market value for Non-invasive Pulse Wave Tonometer in 2022?

As of 2022, the Non-invasive Pulse Wave Tonometer market is slated to reach a valuation of US$ 104.3 Million

At what rate will the Non-invasive Pulse Wave Tonometer market flourish from 2022 to 2032?

From 2022 to 2032, sales of Non-invasive Pulse Wave Tonometer is expected to grow at a 5.8% CAGR

What is the expected market value for Non-invasive Pulse Wave Tonometer in 2032?

By 2032, Future Market Insights expects the Non-invasive Pulse Wave Tonometer market to reach US$ 194 Million.

Table of Content

1. Executive Summary | Non-invasive Pulse Wave Tonometer Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Analysis 2016 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ million) Analysis, 2016 to 2021

    4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) Analysis By Indication, 2016 to 2021

    5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Indication, 2022 to 2032

        5.3.1. Hypertension

        5.3.2. Renal Disease

        5.3.3. COPD

        5.3.4. Diabetes

        5.3.5. Heart Failure

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Indication, 2016 to 2021

    5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032

6. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) Analysis By End User, 2016 to 2021

    6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

7. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ million) Analysis By Region, 2016 to 2021

    7.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Indication

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Indication

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Indication

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Indication

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. The United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Indication

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Indication

        10.3.3. By End User

    10.4. Key Takeaways

11. South Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Singapore

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Indication

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Indication

        11.3.3. By End User

    11.4. Key Takeaways

12. East Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Indication

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Indication

        12.3.3. By End User

    12.4. Key Takeaways

13. Oceania Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Indication

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Indication

        13.3.3. By End User

    13.4. Key Takeaways

14. MEA Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

    14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Indication

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Indication

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Analysis

    15.1. The USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Indication

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Indication

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Indication

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Indication

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Indication

            15.5.2.2. By End User

    15.6. The United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Indication

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Indication

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Indication

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Indication

            15.9.2.2. By End User

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Indication

            15.10.2.2. By End User

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Indication

            15.11.2.2. By End User

    15.12. Singapore

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Indication

            15.12.2.2. By End User

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Indication

            15.13.2.2. By End User

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Indication

            15.14.2.2. By End User

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Indication

            15.15.2.2. By End User

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Indication

            15.16.2.2. By End User

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Indication

            15.17.2.2. By End User

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Indication

            15.18.2.2. By End User

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Indication

            15.19.2.2. By End User

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Indication

            15.20.2.2. By End User

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Indication

            15.21.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Indication

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. ADInstruments

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Millar

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. DiaTecne s.r.l.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. AtCor Medical Pty Ltd.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Haag Streit AG

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Ametek Industries Technology

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Ray Vision International Corporation

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Crystalvue Medical

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Shanghai Vowish Optical Co., Ltd.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

MRI Pulse Oximeters Market

February 2022

REP-GB-10020

July 2022

188 pages

Healthcare

Pulse Lavage Market

June 2019

REP-GB-9651

June 2022

333 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Non-invasive Pulse Wave Tonometer Market